Natus Medical (BABY) Tops Q1 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts BABY Hot Sheet
Price: $26.75 --0%
Financial Fact:
Total operating expenses: 42.86M
Today's EPS Names:
FUSE, INM, TRI, More
Financial Fact:
Total operating expenses: 42.86M
Today's EPS Names:
FUSE, INM, TRI, More
Join SI Premium – FREE
Natus Medical (NASDAQ: BABY) reported Q1 EPS of $0.34, $0.04 better than the analyst estimate of $0.30. Revenue for the quarter came in at $87.3 million versus the consensus estimate of $90.47 million.
GUIDANCE:
Natus Medical sees Q2 2016 EPS of $0.35-$0.36, versus the consensus of $0.37. Natus Medical sees Q2 2016 revenue of $92.0-93.0 million, versus the consensus of $93.9 million.
For earnings history and earnings-related data on Natus Medical (BABY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ultragenyx Pharma (RARE) Misses Q3 EPS by 6c; Offers Guidance
- Essential Utilities, Inc. (WTRG) Tops Q3 EPS by 4c
- Ferroglobe (GSM) Misses Q3 EPS by 3c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
